Published in FDA Law Weekly, September 15th, 2005
The combined company will provide current and future healthcare partners with the greatest reprocessing savings opportunities, more available product services, enhanced field service levels, an undeniable guarantee of quality and U.S. Food & Drug Administration (FDA) compliance, and a continuous stream of new product services from our engineering and product development team as well as unparalleled environmental initiatives.
In order to capitalize on the rapidly expanding...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly